Allergychoices is the #1 choice for giving providers and patients access to effective, affordable and safe allergy drop immunotherapy.
"Having experienced 30 prior years of intermittent allergy shots, I can definitely say that sublingual immunotherapy is far superior to allergy shots in both effectiveness and convenience on a daily basis and especially when traveling. Easy to maintain adherence to treatment."
— Allergychoices' Pharmacy Patient
What Sets Allergychoices Apart?
Protocol with 50+ years
of Clinical Use
97% Patients Reported
96% Patients Reported
La Crosse Method™ Protocol Validated Outcomes
For 50+ years, the La Crosse Method Protocol has given providers and patients access to a personalized, safe, and effective method to treat moderate to debilitating and life-threatening allergies. The Protocol guides providers in treating each patient uniquely based on history, exam, and testing that identifies specific allergies and sensitivity levels.
Supported by published studies and more than 275,000 patients treated, the La Crosse Method is the most widely-used published SLIT protocol in the U.S. Outcomes have been validated through the Validation Institute, an independent team of population health scientists and bio-statisticians who provide objective review to validate healthcare performance.